Oruka Therapeutics, Inc. (ORKA)
80.73
+0.55
(+0.69%)
USD |
NASDAQ |
Oct 07, 10:49
Oruka Therapeutics Market Cap : 4.930B for Oct. 7, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 06, 2026 | 4.897B |
| October 05, 2026 | 5.153B |
| October 02, 2026 | 5.162B |
| October 01, 2026 | 5.094B |
| September 30, 2026 | 5.087B |
| September 29, 2026 | 5.017B |
| September 28, 2026 | 5.141B |
| September 25, 2026 | 5.158B |
| September 24, 2026 | 5.221B |
| September 23, 2026 | 5.492B |
| September 22, 2026 | 5.774B |
| September 21, 2026 | 5.703B |
| September 18, 2026 | 5.799B |
| September 17, 2026 | 5.968B |
| September 16, 2026 | 5.713B |
| September 15, 2026 | 5.631B |
| September 14, 2026 | 5.858B |
| September 11, 2026 | 5.642B |
| September 10, 2026 | 5.597B |
| September 09, 2026 | 5.588B |
| September 08, 2026 | 5.760B |
| September 04, 2026 | 5.650B |
| September 03, 2026 | 5.557B |
| September 02, 2026 | 5.596B |
| September 01, 2026 | 5.625B |
| Date | Value |
|---|---|
| August 31, 2026 | 5.656B |
| August 28, 2026 | 5.566B |
| August 27, 2026 | 5.896B |
| August 26, 2026 | 6.073B |
| August 25, 2026 | 6.218B |
| August 24, 2026 | 6.255B |
| August 21, 2026 | 6.593B |
| August 20, 2026 | 6.404B |
| August 19, 2026 | 6.699B |
| August 18, 2026 | 6.906B |
| August 17, 2026 | 6.880B |
| August 14, 2026 | 6.781B |
| August 13, 2026 | 6.603B |
| August 12, 2026 | 6.559B |
| August 11, 2026 | 6.392B |
| August 10, 2026 | 6.421B |
| August 07, 2026 | 6.035B |
| August 06, 2026 | 6.010B |
| August 05, 2026 | 4.876B |
| August 04, 2026 | 4.923B |
| August 03, 2026 | 4.755B |
| July 31, 2026 | 4.842B |
| July 30, 2026 | 4.909B |
| July 29, 2026 | 4.418B |
| July 28, 2026 | 4.538B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Tenax Therapeutics, Inc. | 61.98M |
| Exicure, Inc. | 6.438M |
| Century Therapeutics, Inc. | 235.61M |
| Absci Corp. | 1.692B |
| Celularity, Inc. | 43.19M |
Market Cap Related Metrics
| Price to Book Value | 4.435 |
| Price | 80.73 |
| Earnings Yield | -3.05% |